Advertisement

Culture System of Bile Duct-Like Cystic Structures Derived from Human-Inducible Pluripotent Stem Cells

  • Akihide Kamiya
  • Kazuya Anzai
  • Kota Tsuruya
  • Hiromi Chikada
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1905)

Abstract

Inducible pluripotent stem (iPS) cells are multipotent stem cells that are produced by gene transfer of reprogramming factors to somatic cells. They are thought to be an important source of regenerative medicine because of their pluripotency and self-renewal ability. Although the liver has high regeneration ability, continuous death of hepatocytes due to chronic inflammation leads to liver cirrhosis and liver carcinoma. With regard to such serious liver diseases, liver transplantation is used as a complete cure, but there is a problem of donor shortage. Therefore, transplantation therapy using liver tissue generated from stem cells in vitro is expected.

We are developing a system to induce the differentiation of cholangiocytes, one of important non-parenchymal cells in living liver tissue, from human iPS cells. Bile duct-like cystic structures can be induced by purifying human iPS cell-derived hepatoblasts expressing hepatic progenitor cell surface markers and inducing differentiation under appropriate culture conditions. These cells are considered to be useful in constructing a hepatic organoid that reproduces the liver structure of the living body.

Key words

Hepatic progenitor cells Human iPS cells Induction of hepatic differentiation Long-term proliferation Purification of progenitor cell 

Notes

Acknowledgments

This work was supported in part by the Education and Research Support Center of Tokai University. Some figures have been reproduced from [12]. This work was supported by a Grant-in-Aid for JSPS Fellows and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan.

References

  1. 1.
    Lemaigre FP (2009) Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies. Gastroenterology 137(1):62–79CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Douarin NM (1975) An experimental analysis of liver development. Med Biol 53(6):427–455PubMedPubMedCentralGoogle Scholar
  3. 3.
    Houssaint E (1980) Differentiation of the mouse hepatic primordium. I. An analysis of tissue interactions in hepatocyte differentiation. Cell Differ 9(5):269–279CrossRefPubMedGoogle Scholar
  4. 4.
    Lemaigre F, Zaret KS (2004) Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr Opin Genet Dev 14(5):582–590CrossRefPubMedGoogle Scholar
  5. 5.
    Clotman F, Jacquemin P, Plumb-Rudewiez N, Pierreux CE, Van der Smissen P, Dietz HC, Courtoy PJ, Rousseau GG, Lemaigre FP (2005) Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev 19(16):1849–1854CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Lemaigre FP (2008) Notch signaling in bile duct development: new insights raise new questions. Hepatology 48(2):358–360CrossRefPubMedGoogle Scholar
  7. 7.
    Zhang D, Gates KP, Barske L, Wang G, Lancman JJ, Zeng XI, Groff M, Wang K, Parsons MJ, Crump JG, Dong PDS (2017) Endoderm Jagged induces liver and pancreas duct lineage in zebrafish. Nat Commun 8(1):769CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Oikawa T, Kamiya A, Kakinuma S, Zeniya M, Nishinakamura R, Tajiri H, Nakauchi H (2009) Sall4 regulates cell fate decision in fetal hepatic stem/progenitor cells. Gastroenterology 136(3):1000–1011CrossRefPubMedGoogle Scholar
  9. 9.
    Tanimizu N, Kobayashi S, Ichinohe N, Mitaka T (2014) Downregulation of miR122 by grainyhead-like 2 restricts the hepatocytic differentiation potential of adult liver progenitor cells. Development 141(23):4448–4456CrossRefPubMedGoogle Scholar
  10. 10.
    Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, Zhang RR, Ueno Y, Zheng YW, Koike N, Aoyama S, Adachi Y, Taniguchi H (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499(7459):481–484CrossRefPubMedGoogle Scholar
  11. 11.
    Koui Y, Kido T, Ito T, Oyama H, Chen SW, Katou Y, Shirahige K, Miyajima A (2017) An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells. Stem Cell Rep 9(2):490–498CrossRefGoogle Scholar
  12. 12.
    Yanagida A, Ito K, Chikada H, Nakauchi H, Kamiya A (2013) An in vitro expansion system for generation of human iPS cell-derived hepatic progenitor-like cells exhibiting a bipotent differentiation potential. PLoS One 8(7):e67541CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Dianat N, Dubois-Pot-Schneider H, Steichen C, Desterke C, Leclerc P, Raveux A, Combettes L, Weber A, Corlu A, Dubart-Kupperschmitt A (2014) Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology 60(2):700–714CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Sampaziotis F, de Brito MC, Geti I, Bertero A, Hannan NR, Vallier L (2017) Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells. Nat Protoc 12(4):814–827CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Drenth JP, te Morsche RH, Smink R, Bonifacino JS, Jansen JB (2003) Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet 33(3):345–347CrossRefPubMedGoogle Scholar
  16. 16.
    Davila S, Furu L, Gharavi AG, Tian X, Onoe T, Qian Q, Li A, Cai Y, Kamath PS, King BF, Azurmendi PJ, Tahvanainen P, Kaariainen H, Hockerstedt K, Devuyst O, Pirson Y, Martin RS, Lifton RP, Tahvanainen E, Torres VE, Somlo S (2004) Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 36(6):575–577CrossRefPubMedGoogle Scholar
  17. 17.
    Wills ES, Te Morsche RHM, van Reeuwijk J, Horn N, Geomini I, van de Laarschot LFM, Mans DA, Ueffing M, Boldt K, Drenth JPH, Roepman R (2017) Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling. Hum Mol Genet 26(21):4190–4202CrossRefPubMedGoogle Scholar
  18. 18.
    Itaba N, Wairagu PM, Aramaki N, Yasui T, Matsumi Y, Kono Y, Phan AN, Otsu M, Kunisada T, Nakamura Y, Okano H, Jeong Y, Shiota G (2014) Nuclear receptor gene alteration in human induced pluripotent stem cells with hepatic differentiation propensity. Hepatol Res 44(14):E408–E419CrossRefPubMedGoogle Scholar
  19. 19.
    Yanagida A, Nakauchi H, Kamiya A (2016) Generation and in vitro expansion of hepatic progenitor cells from human iPS cells. Methods Mol Biol 1357:295–310CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Akihide Kamiya
    • 1
    • 2
  • Kazuya Anzai
    • 3
  • Kota Tsuruya
    • 3
  • Hiromi Chikada
    • 1
  1. 1.Department of Molecular Life SciencesTokai University School of MedicineIseharaJapan
  2. 2.Center for Matrix Biology and Medicine, Graduate Scool of MedicineTokai UniversityIseharaJapan
  3. 3.Department of GastroenterologyTokai University School of MedicineIseharaJapan

Personalised recommendations